Reporter cell assay-based functional quantification of TNF-α-antagonists in serum: a proof-of-principle study for adalimumab

Quantification of therapeutic antibodies is commonly based on physico-chemical assays such as enzyme-linked immunoabsorption assays (ELISA) and lately on mass spectrometry. However, the functional integrity of evaluated immunoglobulins is yet not assessed. Consequently, a commercially available repo...

Full description

Saved in:
Bibliographic Details
Main Authors: Schuster, Lukas (Author) , Sauter, Max (Author) , Uhl, Philipp (Author) , Meid, Andreas (Author) , Haefeli, Walter E. (Author) , Weiß, Johanna (Author) , Theile, Dirk (Author)
Format: Article (Journal)
Language:English
Published: 26 February 2020
In: Analytical biochemistry
Year: 2020, Volume: 596
ISSN:1096-0309
DOI:10.1016/j.ab.2020.113646
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ab.2020.113646
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0003269720301780
Get full text
Author Notes:Lukas Schuster, Max Sauter, Philipp Uhl, Andreas Meid, Walter E. Haefeli, Johanna Weiss, Dirk Theile
Description
Summary:Quantification of therapeutic antibodies is commonly based on physico-chemical assays such as enzyme-linked immunoabsorption assays (ELISA) and lately on mass spectrometry. However, the functional integrity of evaluated immunoglobulins is yet not assessed. Consequently, a commercially available reporter cell line was used to quantify the functional concentration of the anti-tumor necrosis factor alpha (TNF-α) antibody adalimumab present in serum of a healthy beagle dog treated with 3 mg intravenous adalimumab (Humira®). HEK-Blue™-hTLR3 cells express a secreted alkaline phosphatase under the control of a nuclear factor kappa B (NF-κB) response element. Its enzymatic activity can be recorded using colorimetry, which reports activity of extracellular NF-κB stimuli such as TNF-α. Using an adalimumab concentration-response calibration curve, the functional concentration of serum adalimumab was estimated to be 4.9 ± 1.4 μg/ml, which was in excellent agreement with ELISA results (4.8 μg/ml). The obtained data suggest that this simple, easy-to-handle reporter cell assay can be used for the functional quantification of adalimumab present in samples from in vitro or pre-clinical in vivo experiments. Moreover, this assay could be used in vitro to compare the pharmacodynamics of adalimumab biosimilars or different anti-TNF-α compounds, respectively.
Item Description:Im Text wird alpha als griechisches Zeichen dargestellt
Gesehen am 24.04.2020
Physical Description:Online Resource
ISSN:1096-0309
DOI:10.1016/j.ab.2020.113646